HSD17B13
HSD17B13 (hydroxysteroid 17-beta dehydrogenase 13, also known as SCDR9 and SDR16C3) is a member of the short-chain dehydrogenase/reductase superfamily. It is located in lipid droplets and is linked to the positive regulation of lipid biosynthetic processes. Browse Assay Genie's current range of HSD17B13 research reagents below, or read on for the biology behind the target.
HSD17B13 belongs to the short-chain dehydrogenase/reductase (SDR) family. On the basis of sequence and annotation, it is predicted to act as an oxidoreductase on the CH-OH group of donors, using NAD or NADP as the acceptor, and to have steroid dehydrogenase activity. The HSD17B13 gene is reported to act upstream of, or within, the positive regulation of lipid biosynthetic processes. UniProt notes that the protein does not show retinol or retinal dehydrogenase activity in vitro, so its physiological substrates are not defined by these data.
The HSD17B13 protein is found in lipid droplets, and UniProt also lists the endoplasmic reticulum and cytoplasm as subcellular locations. This places the enzyme at the site of intracellular lipid storage, which is why it is studied in the context of lipid metabolism. The human gene is on chromosome 4 and encodes a 300-amino-acid protein, with orthologues named Hsd17b13 in mouse and rat, which allows comparative work in rodent models.
HGNC classifies the gene in the short chain dehydrogenase/reductase superfamily. Alternative symbols include SCDR9 and SDR16C3, and the earlier gene name was hydroxysteroid (17-beta) dehydrogenase 13. Researchers working on HSD17B13 often compare it with other hydroxysteroid dehydrogenases, such as the 17-beta and 11-beta isoforms, to separate shared enzyme chemistry from lipid droplet-specific roles. Reagents such as an HSD17B13 antibody, HSD17B13 ELISA kit or recombinant HSD17B13 protein support work on expression and localisation.
HSD17B13 is located in lipid droplets, making it a useful protein for studying how enzymes associate with intracellular lipid stores.
The gene acts upstream of or within positive regulation of lipid biosynthetic processes, which supports studies of lipid metabolic control.
Predicted steroid dehydrogenase and NAD/NADP-dependent oxidoreductase activity makes HSD17B13 relevant to substrate and cofactor studies.
As an SDR superfamily member that lacks retinol dehydrogenase activity in vitro, it is a useful comparator among related hydroxysteroid dehydrogenases.
HSD17B13 is a short-chain dehydrogenase/reductase predicted to have NAD- or NADP-dependent oxidoreductase and steroid dehydrogenase activity. It is located in lipid droplets and acts upstream of or within positive regulation of lipid biosynthetic processes. In vitro, it does not show retinol or retinal dehydrogenase activity.
HSD17B13 is also known as SCDR9 and SDR16C3. The HGNC name is hydroxysteroid 17-beta dehydrogenase 13, and the previous name was hydroxysteroid (17-beta) dehydrogenase 13. UniProt names the protein 17-beta-hydroxysteroid dehydrogenase 13.
Yes. Mouse and rat both have an orthologue named Hsd17b13, so the gene can be studied in common rodent models. Orthologues are not identical to the human protein, so check the datasheet of any product for its validated reactivity.
Other hydroxysteroid dehydrogenases and short-chain dehydrogenase/reductase family members relevant to steroid and lipid metabolism research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q7Z5P4; product specifications from Assay Genie datasheets.